First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc. financial statements
First Tracks Biotherapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | −USD 166.09M | EODHD |
| Cash and equivalents | USD 238.2M | EODHD |
| Total debt | USD 14.11M | EODHD |
First Tracks Biotherapeutics, Inc. financials on 6ix · First Tracks Biotherapeutics, Inc. on 6ix